For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Iovance Biotherapeutics Inc (NASDAQ: IOVA) closed at $1.73 in the last session, down -2.81% from day before closing price of $1.78. In other words, the price has decreased by -$2.81 from its previous closing price. On the day, 16.05 million shares were traded.
Ratios:
We take a closer look at IOVA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 4.18. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 23 ’25 when Puri Raj K. bought 5,600 shares for $1.74 per share. The transaction valued at 9,743 led to the insider holds 206,852 shares of the business.
Vogt Frederick G bought 25,000 shares of IOVA for $42,250 on May 14 ’25. The Interim CEO & General Counsel now owns 374,646 shares after completing the transaction at $1.69 per share. On Nov 12 ’24, another insider, Maynard Ryan D, who serves as the Director of the company, sold 50,000 shares for $10.06 each. As a result, the insider received 503,000 and left with 7,500 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.72 while its Price-to-Book (P/B) ratio in mrq is 0.75.
Stock Price History:
Over the past 52 weeks, IOVA has reached a high of $12.51, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -41.76%, while the 200-Day Moving Average is calculated to be -75.20%.
Shares Statistics:
A total of 333.93M shares are outstanding, with a floating share count of 271.58M. Insiders hold about 18.67% of the company’s shares, while institutions hold 64.01% stake in the company.
